2nd Longevity Therapeutics Summit 2020

Memo

Aging population is a prominent risk across the world. While major pharmas have spent decades searching for the best treatment for age-related diseases, biotechs have been secretly paving their research for longevity therapies – which could be our answers to improving our lifespan, delaying or even preventing the onset of age-related conditions. Building on the success in 2019, the 2nd Longevity Therapeutics 2020 Summit will once again return to San Francisco. As the only industry-led and end-to-end longevity meeting, we will hear success stories in the last 12 months and explore what’s next to help you accelerate your pipeline into clinic! Make this your 2020 must attend meeting to network with 80+ senior CSOs, CEOs, Research Scientists, Academics and Investors committed to making a change to aging diseases! URLs: Tickets https://go.evvnt.com/532209-1?pid=5569,Brochure https://go.evvnt.com/532209-3?pid=5569. Prices:2 Day Conference - Industry (1st Release): USD 1499.00,2 Day Conference - Academic (1st Release): USD 1049.00,2 Day Conference - Industry (Standard): USD 2099.00,2 Day Conference - Academic (Standard): USD 1469.00. Speakers: Andrea Maier, Divisional Director Medicine and Community Care and Professorial Fellow General Medicine and Aged Care, University of Melbourne, Dana Larocca, VP, Discovery Research, AgeX Therapeutics, Gino Cortopassi, Professor, Molecular Biosciences, University of California Davis, Gordon Lithgow, Professor, Buck Institute for Research on Aging, Hanadie Yousef, CEO and Co-Founder, Juvena Therapeutics, Jay Sarkar, Co-Founder and CTO, Turn Biotechnologies, Jean-Marc, Brondello Research, Scientist INSERM, Joan Mannick, CMO, ResTORbio, John Lewis, CSO Oisin, Biotechnologies, Julie Andersen Professor, Neurodegeneration, Buck Institute for Research on Aging, Kelsey Moody, CEO, Ichor Therapeutics, Inc., Kristen Fortney, CEO, BioAge Labs, Lewis Gruber, CEO, Co-Founder and CSO, Siwa Therapeutics, Marc Ramis-Castelltort, Co-Founder and CEO, Senolytic Therapeutics, Marco Quarta, CEO and Co-Founder, Rubedo Life Sciences, Michael Fosselm Founder and President, Telocyte, Natalie Yivgi-Ohana, Co-Founder and CEO, Minovia Therapeutics, Nathaniel David, Co-Founder and President, Unity Biotechnology, Nir Barzilai, Director - Institute for Aging Research and Professor - Medicine Endocrinology and Genetics, Albert Einstein College of Medicine, Pan Zheng Professor, Department of Surgery, University of Maryland Baltimore, Reason, Founder and CEO, Repair Biotechnologies, Rich Allsopp, Professor, John A. Burns School of Medicine, University of Hawaii, Richard Marshak, CEO, Mount Tam Biotechnologies, Ronald Kohanski, Deputy Director – Division of Aging Biology, National Institute on Aging, NIH, Sergio Ruiz, Managing Partner, Methuselah Fund. Time: 5:00 pm to 1:00 am. Venue details: Holiday Inn San Francisco-Golden Gateway, 1500 Van Ness Avenue, San Francisco, California, 94109, United States.